Both T2DM and cancer are characterised by elevated secretion of proinflammatory cytokines (e.g., IL-6, TNF-α, IL-1β), which can cross the blood–brain barrier and activate microglia, thereby contributing to depressive and anxiety symptoms. Here, IL1B is linked to cancer.